Your browser doesn't support javascript.
loading
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing.
Bellocchi, Maria Concetta; Scutari, Rossana; Carioti, Luca; Iannetta, Marco; Marchegiani, Greta; Piermatteo, Lorenzo; Coppola, Luigi; Tedde, Simona; Duca, Leonardo; Malagnino, Vincenzo; Ansaldo, Lorenzo; Braccialarghe, Neva; D Anna, Stefano; Santoro, Maria Mercedes; Di Lorenzo, Andrea; Salpini, Romina; Teti, Elisabetta; Svicher, Valentina; Andreoni, Massimo; Sarmati, Loredana; Ceccherini-Silberstein, Francesca.
Affiliation
  • Bellocchi MC; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Scutari R; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
  • Carioti L; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Iannetta M; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Marchegiani G; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Piermatteo L; Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Coppola L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Tedde S; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Duca L; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Malagnino V; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Ansaldo L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Braccialarghe N; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • D Anna S; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Santoro MM; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Di Lorenzo A; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Salpini R; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Teti E; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Svicher V; Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Andreoni M; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Sarmati L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Viruses ; 15(8)2023 08 09.
Article in En | MEDLINE | ID: mdl-37632054
ABSTRACT
In this study, we provided a retrospective overview in order to better define SARS-CoV-2 variants circulating in Italy during the first two years of the pandemic, by characterizing the spike mutational profiles and their association with viral load (expressed as ct values), N-glycosylation pattern, hospitalization and vaccination. Next-generation sequencing (NGS) data were obtained from 607 individuals (among them, 298 vaccinated and/or 199 hospitalized). Different rates of hospitalization were observed over time and among variants of concern (VOCs), both in the overall population and in vaccinated individuals (Alpha 40.7% and 31.3%, Beta 0%, Gamma 36.5% and 44.4%, Delta 37.8% and 40.2% and Omicron 11.2% and 7.1%, respectively, both p-values < 0.001). Approximately 32% of VOC-infected individuals showed at least one atypical major spike mutation (intra-prevalence > 90%), with a distribution differing among the strains (22.9% in Alpha, 14.3% in Beta, 41.8% in Gamma, 46.5% in Delta and 15.4% in Omicron, p-value < 0.001). Overall, significantly less atypical variability was observed in vaccinated individuals than unvaccinated individuals; nevertheless, vaccinated people who needed hospitalization showed an increase in atypical variability compared to vaccinated people that did not need hospitalization. Only 5/607 samples showed a different putative N-glycosylation pattern, four within the Delta VOC and one within the Omicron BA.2.52 sublineage. Interestingly, atypical minor mutations (intra-prevalence < 20%) were associated with higher Ct values and a longer duration of infection. Our study reports updated information on the temporal circulation of SARS-CoV-2 variants circulating in Central Italy and their association with hospitalization and vaccination. The results underline how SARS-CoV-2 has changed over time and how the vaccination strategy has contributed to reducing severity and hospitalization for this infection in Italy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Viruses Year: 2023 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Viruses Year: 2023 Type: Article Affiliation country: Italy